Regulation & law · 03/12/1996
FDA Releases Documents on Clinical Hold Procedures for IND Applications
The FDA has made available two documents outlining the procedures for issuing and reviewing responses to clinical hold notices for Investigational New Drug (IND) applications, aiming to clarify the agency's policy on handling these situations.
Original source language: Federal Register — All DocumentsOpen original release →